Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Immunex reports anticancer activity of Flt3 ligand

June 6, 1997

ImClone reaches milestone in small cell lung cancer treatment collaboration

June 6, 1997

Techniclone finalizes acquisition of Peregrine

June 5, 1997

Biomira notified of patent allowance for Theratope

May 30, 1997

AltaRex initiates U.S. phase IIb trial with Ovarex

May 28, 1997

Bexxar as first-line therapy for non-Hodgkin's lymphoma

May 26, 1997

Preliminary phase II and phase I/II results for Allovectin-7

May 22, 1997

Preliminary results indicate potential for AML treatment

May 21, 1997

Techniclone reports promising results from brain cancer treatment study

May 21, 1997

Somatix reports promising results from melanoma vaccine trials

May 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...